nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—CYP2C8—Amitriptyline—migraine	0.111	0.217	CbGbCtD
Trametinib—CYP2C8—Valproic Acid—migraine	0.101	0.198	CbGbCtD
Trametinib—CYP2C8—Verapamil—migraine	0.0882	0.172	CbGbCtD
Trametinib—CYP3A4—Propranolol—migraine	0.0521	0.102	CbGbCtD
Trametinib—CYP3A4—Amitriptyline—migraine	0.0451	0.0881	CbGbCtD
Trametinib—CYP3A4—Valproic Acid—migraine	0.0411	0.0803	CbGbCtD
Trametinib—CYP3A4—Topiramate—migraine	0.0371	0.0724	CbGbCtD
Trametinib—CYP3A4—Verapamil—migraine	0.0358	0.0699	CbGbCtD
Trametinib—MAP2K1—Endothelin Pathways—RAMP1—migraine	0.0054	0.0319	CbGpPWpGaD
Trametinib—MAP2K1—neck—migraine	0.00463	0.133	CbGeAlD
Trametinib—MAP2K1—brainstem—migraine	0.00354	0.102	CbGeAlD
Trametinib—MAP2K2—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2C—migraine	0.00353	0.0209	CbGpPWpGaD
Trametinib—MAP2K2—trigeminal ganglion—migraine	0.00352	0.101	CbGeAlD
Trametinib—MAP2K2—Cellular roles of Anthrax toxin—PGR—migraine	0.00333	0.0197	CbGpPWpGaD
Trametinib—MAP2K1—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2C—migraine	0.0033	0.0195	CbGpPWpGaD
Trametinib—MAP2K2—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—migraine	0.00322	0.019	CbGpPWpGaD
Trametinib—MAP2K1—Cellular roles of Anthrax toxin—PGR—migraine	0.00312	0.0184	CbGpPWpGaD
Trametinib—MAP2K1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—migraine	0.00301	0.0178	CbGpPWpGaD
Trametinib—MAP2K1—cardiovascular system—migraine	0.00289	0.083	CbGeAlD
Trametinib—MAP2K2—L1CAM interactions—SCN1A—migraine	0.00258	0.0152	CbGpPWpGaD
Trametinib—MAP2K2—cardiovascular system—migraine	0.00254	0.0731	CbGeAlD
Trametinib—MAP2K1—L1CAM interactions—SCN1A—migraine	0.00241	0.0143	CbGpPWpGaD
Trametinib—MAP2K2—L1CAM interactions—SCN2A—migraine	0.00219	0.013	CbGpPWpGaD
Trametinib—MAP2K2—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—migraine	0.00216	0.0128	CbGpPWpGaD
Trametinib—MAP2K1—Ras signaling in the CD4+ TCR pathway—FOS—migraine	0.00215	0.0127	CbGpPWpGaD
Trametinib—MAP2K1—Endothelin Pathways—EDNRA—migraine	0.00215	0.0127	CbGpPWpGaD
Trametinib—MAP2K1—Endothelin Pathways—CALCA—migraine	0.00207	0.0122	CbGpPWpGaD
Trametinib—MAP2K1—L1CAM interactions—SCN2A—migraine	0.00205	0.0121	CbGpPWpGaD
Trametinib—MAP2K1—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—migraine	0.00202	0.012	CbGpPWpGaD
Trametinib—MAP2K2—B Cell Receptor Signaling Pathway—MEF2D—migraine	0.00199	0.0117	CbGpPWpGaD
Trametinib—MAP2K1—head—migraine	0.00196	0.0562	CbGeAlD
Trametinib—MAP2K1—B Cell Receptor Signaling Pathway—MEF2D—migraine	0.00186	0.011	CbGpPWpGaD
Trametinib—MAP2K1—nervous system—migraine	0.00185	0.0533	CbGeAlD
Trametinib—MAP2K1—central nervous system—migraine	0.00179	0.0513	CbGeAlD
Trametinib—MAP2K1—cerebellum—migraine	0.00174	0.0502	CbGeAlD
Trametinib—MAP2K2—head—migraine	0.00172	0.0495	CbGeAlD
Trametinib—MAP2K2—nervous system—migraine	0.00163	0.0469	CbGeAlD
Trametinib—MAP2K1—Estrogen signaling pathway—ESR1—migraine	0.00161	0.0095	CbGpPWpGaD
Trametinib—MAP2K2—central nervous system—migraine	0.00157	0.0452	CbGeAlD
Trametinib—MAP2K2—cerebellum—migraine	0.00154	0.0442	CbGeAlD
Trametinib—MAP2K1—Estrogen signaling pathway—FOS—migraine	0.00145	0.00856	CbGpPWpGaD
Trametinib—MAP2K1—brain—migraine	0.00142	0.0408	CbGeAlD
Trametinib—MAP2K2—Endothelins—EDNRA—migraine	0.00137	0.0081	CbGpPWpGaD
Trametinib—MAP2K2—EGF/EGFR Signaling Pathway—MEF2D—migraine	0.00132	0.00779	CbGpPWpGaD
Trametinib—MAP2K1—Endothelins—EDNRA—migraine	0.00128	0.00758	CbGpPWpGaD
Trametinib—MAP2K2—brain—migraine	0.00125	0.0359	CbGeAlD
Trametinib—MAP2K1—EGF/EGFR Signaling Pathway—MEF2D—migraine	0.00123	0.00729	CbGpPWpGaD
Trametinib—MAP2K2—Nongenotropic Androgen signaling—FOS—migraine	0.00122	0.00721	CbGpPWpGaD
Trametinib—MAP2K2—PDGFR-beta signaling pathway—LRP1—migraine	0.00118	0.007	CbGpPWpGaD
Trametinib—MAP2K1—Nongenotropic Androgen signaling—FOS—migraine	0.00114	0.00674	CbGpPWpGaD
Trametinib—MAP2K2—Signaling of Hepatocyte Growth Factor Receptor—FOS—migraine	0.00113	0.00669	CbGpPWpGaD
Trametinib—MAP2K1—PDGFR-beta signaling pathway—LRP1—migraine	0.00111	0.00655	CbGpPWpGaD
Trametinib—MAP2K2—SHP2 signaling—BDNF—migraine	0.00109	0.00646	CbGpPWpGaD
Trametinib—MAP2K1—Trk receptor signaling mediated by the MAPK pathway—FOS—migraine	0.00106	0.00626	CbGpPWpGaD
Trametinib—MAP2K1—Signaling of Hepatocyte Growth Factor Receptor—FOS—migraine	0.00106	0.00626	CbGpPWpGaD
Trametinib—MAP2K2—GMCSF-mediated signaling events—FOS—migraine	0.00106	0.00626	CbGpPWpGaD
Trametinib—MAP2K1—SHP2 signaling—BDNF—migraine	0.00102	0.00604	CbGpPWpGaD
Trametinib—MAP2K2—IL-5 Signaling Pathway—FOS—migraine	0.000994	0.00588	CbGpPWpGaD
Trametinib—MAP2K1—FOXM1 transcription factor network—ESR1—migraine	0.000992	0.00587	CbGpPWpGaD
Trametinib—MAP2K1—GMCSF-mediated signaling events—FOS—migraine	0.00099	0.00585	CbGpPWpGaD
Trametinib—MAP2K1—Neurotrophic factor-mediated Trk receptor signaling—BDNF—migraine	0.000982	0.00581	CbGpPWpGaD
Trametinib—MAP2K2—ErbB2/ErbB3 signaling events—FOS—migraine	0.000974	0.00576	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—SCN1A—migraine	0.000973	0.00576	CbGpPWpGaD
Trametinib—MAP2K2—IL-2 Signaling Pathway—FOS—migraine	0.000956	0.00565	CbGpPWpGaD
Trametinib—MAP2K1—PDGF Pathway—FOS—migraine	0.000949	0.00561	CbGpPWpGaD
Trametinib—MAP2K2—FCERI mediated MAPK activation—FOS—migraine	0.000938	0.00555	CbGpPWpGaD
Trametinib—MAP2K1—IL-5 Signaling Pathway—FOS—migraine	0.00093	0.0055	CbGpPWpGaD
Trametinib—MAP2K1—Aryl Hydrocarbon Receptor—ESR1—migraine	0.000923	0.00546	CbGpPWpGaD
Trametinib—MAP2K1—ErbB2/ErbB3 signaling events—FOS—migraine	0.000912	0.00539	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—SCN1A—migraine	0.000911	0.00539	CbGpPWpGaD
Trametinib—MAP2K1—IL-2 Signaling Pathway—FOS—migraine	0.000894	0.00529	CbGpPWpGaD
Trametinib—MAP2K1—FOXM1 transcription factor network—FOS—migraine	0.000894	0.00529	CbGpPWpGaD
Trametinib—MAP2K1—FCERI mediated MAPK activation—FOS—migraine	0.000878	0.00519	CbGpPWpGaD
Trametinib—MAP2K2—Structural Pathway of Interleukin 1 (IL-1)—FOS—migraine	0.000874	0.00517	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000871	0.00515	CbGpPWpGaD
Trametinib—MAP2K2—Cellular roles of Anthrax toxin—TNF—migraine	0.000862	0.0051	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—SCN2A—migraine	0.000828	0.00489	CbGpPWpGaD
Trametinib—MAP2K1—Structural Pathway of Interleukin 1 (IL-1)—FOS—migraine	0.000817	0.00483	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000815	0.00482	CbGpPWpGaD
Trametinib—MAP2K1—Cellular roles of Anthrax toxin—TNF—migraine	0.000807	0.00477	CbGpPWpGaD
Trametinib—MAP2K1—IL-3 Signaling Pathway—FOS—migraine	0.000791	0.00468	CbGpPWpGaD
Trametinib—MAP2K2—IL2-mediated signaling events—FOS—migraine	0.000782	0.00462	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—SCN2A—migraine	0.000774	0.00458	CbGpPWpGaD
Trametinib—MAP2K2—MAP kinase activation in TLR cascade—FOS—migraine	0.000759	0.00449	CbGpPWpGaD
Trametinib—MAP2K1—IL2-mediated signaling events—FOS—migraine	0.000731	0.00433	CbGpPWpGaD
Trametinib—MAP2K2—Kit receptor signaling pathway—FOS—migraine	0.000728	0.00431	CbGpPWpGaD
Trametinib—MAP2K1—RANKL/RANK Signaling Pathway—FOS—migraine	0.000721	0.00426	CbGpPWpGaD
Trametinib—MAP2K1—MAP kinase activation in TLR cascade—FOS—migraine	0.00071	0.0042	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—PGR—migraine	0.00071	0.0042	CbGpPWpGaD
Trametinib—MAP2K2—Fc-epsilon receptor I signaling in mast cells—FOS—migraine	0.000709	0.00419	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—SCN1A—migraine	0.000695	0.00411	CbGpPWpGaD
Trametinib—Oedema peripheral—Valproic Acid—migraine	0.000694	0.00244	CcSEcCtD
Trametinib—Connective tissue disorder—Valproic Acid—migraine	0.000692	0.00243	CcSEcCtD
Trametinib—MAP2K2—Endothelins—FOS—migraine	0.000691	0.00409	CbGpPWpGaD
Trametinib—Urethral disorder—Valproic Acid—migraine	0.00069	0.00243	CcSEcCtD
Trametinib—Hyperhidrosis—Verapamil—migraine	0.000682	0.0024	CcSEcCtD
Trametinib—MAP2K1—Kit receptor signaling pathway—FOS—migraine	0.000681	0.00403	CbGpPWpGaD
Trametinib—Asthenia—Amitriptyline—migraine	0.000676	0.00238	CcSEcCtD
Trametinib—MAP2K2—Oncostatin M Signaling Pathway—FOS—migraine	0.000674	0.00399	CbGpPWpGaD
Trametinib—MAP2K2—Leptin signaling pathway—ESR1—migraine	0.000667	0.00394	CbGpPWpGaD
Trametinib—Decreased appetite—Propranolol—migraine	0.000667	0.00234	CcSEcCtD
Trametinib—Pruritus—Amitriptyline—migraine	0.000666	0.00234	CcSEcCtD
Trametinib—MAP2K2—Downstream signaling in naïve CD8+ T cells—FOS—migraine	0.000666	0.00394	CbGpPWpGaD
Trametinib—Blood creatinine increased—Topiramate—migraine	0.000665	0.00234	CcSEcCtD
Trametinib—MAP2K1—Signaling by ERBB4—PGR—migraine	0.000664	0.00393	CbGpPWpGaD
Trametinib—MAP2K1—Fc-epsilon receptor I signaling in mast cells—FOS—migraine	0.000663	0.00392	CbGpPWpGaD
Trametinib—Gastrointestinal disorder—Propranolol—migraine	0.000662	0.00233	CcSEcCtD
Trametinib—Fatigue—Propranolol—migraine	0.000661	0.00232	CcSEcCtD
Trametinib—Dehydration—Topiramate—migraine	0.00066	0.00232	CcSEcCtD
Trametinib—Epistaxis—Timolol—migraine	0.000659	0.00232	CcSEcCtD
Trametinib—Eye disorder—Valproic Acid—migraine	0.000658	0.00231	CcSEcCtD
Trametinib—Hyperglycaemia—Gabapentin—migraine	0.000658	0.00231	CcSEcCtD
Trametinib—Constipation—Propranolol—migraine	0.000656	0.00231	CcSEcCtD
Trametinib—Infestation—Gabapentin—migraine	0.00065	0.00229	CcSEcCtD
Trametinib—Infestation NOS—Gabapentin—migraine	0.00065	0.00229	CcSEcCtD
Trametinib—MAP2K1—Developmental Biology—SCN1A—migraine	0.00065	0.00384	CbGpPWpGaD
Trametinib—Abdominal pain upper—Topiramate—migraine	0.000648	0.00228	CcSEcCtD
Trametinib—MAP2K1—Endothelins—FOS—migraine	0.000647	0.00382	CbGpPWpGaD
Trametinib—Hypokalaemia—Topiramate—migraine	0.000646	0.00227	CcSEcCtD
Trametinib—Diarrhoea—Amitriptyline—migraine	0.000645	0.00227	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Verapamil—migraine	0.000643	0.00226	CcSEcCtD
Trametinib—Aspartate aminotransferase increased—Topiramate—migraine	0.000639	0.00225	CcSEcCtD
Trametinib—Renal failure—Gabapentin—migraine	0.000639	0.00225	CcSEcCtD
Trametinib—Angiopathy—Valproic Acid—migraine	0.000639	0.00225	CcSEcCtD
Trametinib—Insomnia—Verapamil—migraine	0.000638	0.00224	CcSEcCtD
Trametinib—Bradycardia—Timolol—migraine	0.000638	0.00224	CcSEcCtD
Trametinib—Mediastinal disorder—Valproic Acid—migraine	0.000635	0.00223	CcSEcCtD
Trametinib—Stomatitis—Gabapentin—migraine	0.000634	0.00223	CcSEcCtD
Trametinib—Urinary tract infection—Gabapentin—migraine	0.000632	0.00222	CcSEcCtD
Trametinib—Chills—Valproic Acid—migraine	0.000632	0.00222	CcSEcCtD
Trametinib—MAP2K1—Oncostatin M Signaling Pathway—FOS—migraine	0.000631	0.00373	CbGpPWpGaD
Trametinib—Arrhythmia—Valproic Acid—migraine	0.000629	0.00221	CcSEcCtD
Trametinib—Gastrointestinal pain—Propranolol—migraine	0.000627	0.00221	CcSEcCtD
Trametinib—Alanine aminotransferase increased—Topiramate—migraine	0.000626	0.0022	CcSEcCtD
Trametinib—MAP2K1—Leptin signaling pathway—ESR1—migraine	0.000624	0.00369	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling in naïve CD8+ T cells—FOS—migraine	0.000623	0.00368	CbGpPWpGaD
Trametinib—MAP2K1—TSH signaling pathway—FOS—migraine	0.000623	0.00368	CbGpPWpGaD
Trametinib—Dizziness—Amitriptyline—migraine	0.000623	0.00219	CcSEcCtD
Trametinib—Haematuria—Gabapentin—migraine	0.00062	0.00218	CcSEcCtD
Trametinib—Oedema peripheral—Timolol—migraine	0.000617	0.00217	CcSEcCtD
Trametinib—Mental disorder—Valproic Acid—migraine	0.000617	0.00217	CcSEcCtD
Trametinib—Connective tissue disorder—Timolol—migraine	0.000616	0.00217	CcSEcCtD
Trametinib—MAP2K1—BCR signaling pathway—FOS—migraine	0.000615	0.00364	CbGpPWpGaD
Trametinib—Epistaxis—Gabapentin—migraine	0.000613	0.00216	CcSEcCtD
Trametinib—Malnutrition—Valproic Acid—migraine	0.000613	0.00216	CcSEcCtD
Trametinib—Fatigue—Verapamil—migraine	0.000608	0.00214	CcSEcCtD
Trametinib—Abdominal pain—Propranolol—migraine	0.000606	0.00213	CcSEcCtD
Trametinib—Body temperature increased—Propranolol—migraine	0.000606	0.00213	CcSEcCtD
Trametinib—Constipation—Verapamil—migraine	0.000603	0.00212	CcSEcCtD
Trametinib—Pancreatitis—Topiramate—migraine	0.000602	0.00211	CcSEcCtD
Trametinib—MAP2K2—TRAF6 Mediated Induction of proinflammatory cytokines—FOS—migraine	0.000601	0.00356	CbGpPWpGaD
Trametinib—Dysgeusia—Valproic Acid—migraine	0.0006	0.00211	CcSEcCtD
Trametinib—Vomiting—Amitriptyline—migraine	0.000599	0.00211	CcSEcCtD
Trametinib—Bradycardia—Gabapentin—migraine	0.000594	0.00209	CcSEcCtD
Trametinib—Rash—Amitriptyline—migraine	0.000594	0.00209	CcSEcCtD
Trametinib—Dermatitis—Amitriptyline—migraine	0.000593	0.00209	CcSEcCtD
Trametinib—Back pain—Valproic Acid—migraine	0.000593	0.00208	CcSEcCtD
Trametinib—MAP2K2—Developmental Biology—SCN2A—migraine	0.000591	0.00349	CbGpPWpGaD
Trametinib—Headache—Amitriptyline—migraine	0.00059	0.00207	CcSEcCtD
Trametinib—Muscle spasms—Valproic Acid—migraine	0.000589	0.00207	CcSEcCtD
Trametinib—Abdominal discomfort—Topiramate—migraine	0.000588	0.00207	CcSEcCtD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—TGFBR2—migraine	0.000588	0.00348	CbGpPWpGaD
Trametinib—Eye disorder—Timolol—migraine	0.000586	0.00206	CcSEcCtD
Trametinib—Haemorrhage—Gabapentin—migraine	0.000584	0.00205	CcSEcCtD
Trametinib—Cardiac disorder—Timolol—migraine	0.000582	0.00205	CcSEcCtD
Trametinib—Vision blurred—Valproic Acid—migraine	0.000578	0.00203	CcSEcCtD
Trametinib—Urinary tract disorder—Gabapentin—migraine	0.000576	0.00203	CcSEcCtD
Trametinib—Oedema peripheral—Gabapentin—migraine	0.000575	0.00202	CcSEcCtD
Trametinib—Neutropenia—Topiramate—migraine	0.000574	0.00202	CcSEcCtD
Trametinib—Connective tissue disorder—Gabapentin—migraine	0.000574	0.00202	CcSEcCtD
Trametinib—Urethral disorder—Gabapentin—migraine	0.000572	0.00201	CcSEcCtD
Trametinib—Angiopathy—Timolol—migraine	0.000569	0.002	CcSEcCtD
Trametinib—Anaemia—Valproic Acid—migraine	0.000567	0.00199	CcSEcCtD
Trametinib—Mediastinal disorder—Timolol—migraine	0.000565	0.00199	CcSEcCtD
Trametinib—MAP2K1—TRAF6 Mediated Induction of proinflammatory cytokines—FOS—migraine	0.000562	0.00333	CbGpPWpGaD
Trametinib—Arrhythmia—Timolol—migraine	0.00056	0.00197	CcSEcCtD
Trametinib—Nausea—Amitriptyline—migraine	0.00056	0.00197	CcSEcCtD
Trametinib—MAP2K2—Amyotrophic lateral sclerosis (ALS)—TNF—migraine	0.000557	0.00329	CbGpPWpGaD
Trametinib—Hyperglycaemia—Topiramate—migraine	0.000553	0.00195	CcSEcCtD
Trametinib—MAP2K1—Developmental Biology—SCN2A—migraine	0.000552	0.00327	CbGpPWpGaD
Trametinib—Asthenia—Propranolol—migraine	0.00055	0.00193	CcSEcCtD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—TGFBR2—migraine	0.00055	0.00325	CbGpPWpGaD
Trametinib—Mental disorder—Timolol—migraine	0.000549	0.00193	CcSEcCtD
Trametinib—Leukopenia—Valproic Acid—migraine	0.000549	0.00193	CcSEcCtD
Trametinib—Infestation—Topiramate—migraine	0.000547	0.00192	CcSEcCtD
Trametinib—Infestation NOS—Topiramate—migraine	0.000547	0.00192	CcSEcCtD
Trametinib—Malnutrition—Timolol—migraine	0.000546	0.00192	CcSEcCtD
Trametinib—Erythema—Timolol—migraine	0.000546	0.00192	CcSEcCtD
Trametinib—Eye disorder—Gabapentin—migraine	0.000545	0.00192	CcSEcCtD
Trametinib—MAP2K2—MyD88 cascade initiated on plasma membrane—FOS—migraine	0.000544	0.00322	CbGpPWpGaD
Trametinib—Cardiac disorder—Gabapentin—migraine	0.000542	0.0019	CcSEcCtD
Trametinib—MAP2K2—Developmental Biology—MEF2D—migraine	0.00054	0.00319	CbGpPWpGaD
Trametinib—MAP2K2—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—FOS—migraine	0.000539	0.00319	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000538	0.00318	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000538	0.00318	CbGpPWpGaD
Trametinib—Renal failure—Topiramate—migraine	0.000538	0.00189	CcSEcCtD
Trametinib—Cough—Valproic Acid—migraine	0.000535	0.00188	CcSEcCtD
Trametinib—Dysgeusia—Timolol—migraine	0.000534	0.00188	CcSEcCtD
Trametinib—Stomatitis—Topiramate—migraine	0.000533	0.00187	CcSEcCtD
Trametinib—Urinary tract infection—Topiramate—migraine	0.000532	0.00187	CcSEcCtD
Trametinib—Hypertension—Valproic Acid—migraine	0.000529	0.00186	CcSEcCtD
Trametinib—MAP2K2—MyD88 dependent cascade initiated on endosome—FOS—migraine	0.000529	0.00313	CbGpPWpGaD
Trametinib—MAP2K2—BDNF signaling pathway—BDNF—migraine	0.000528	0.00312	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000528	0.00312	CbGpPWpGaD
Trametinib—Mediastinal disorder—Gabapentin—migraine	0.000526	0.00185	CcSEcCtD
Trametinib—Diarrhoea—Propranolol—migraine	0.000525	0.00185	CcSEcCtD
Trametinib—Chills—Gabapentin—migraine	0.000524	0.00184	CcSEcCtD
Trametinib—Myalgia—Valproic Acid—migraine	0.000522	0.00183	CcSEcCtD
Trametinib—Arthralgia—Valproic Acid—migraine	0.000522	0.00183	CcSEcCtD
Trametinib—Haematuria—Topiramate—migraine	0.000522	0.00183	CcSEcCtD
Trametinib—MAP2K2—TCR Signaling Pathway—FOS—migraine	0.00052	0.00307	CbGpPWpGaD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000518	0.00182	CcSEcCtD
Trametinib—Epistaxis—Topiramate—migraine	0.000516	0.00181	CcSEcCtD
Trametinib—Vision blurred—Timolol—migraine	0.000514	0.00181	CcSEcCtD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000513	0.00303	CbGpPWpGaD
Trametinib—Mental disorder—Gabapentin—migraine	0.000511	0.0018	CcSEcCtD
Trametinib—MAP2K2—Toll Like Receptor 9 (TLR9) Cascade—FOS—migraine	0.00051	0.00302	CbGpPWpGaD
Trametinib—Dry mouth—Valproic Acid—migraine	0.00051	0.00179	CcSEcCtD
Trametinib—MAP2K1—MyD88 cascade initiated on plasma membrane—FOS—migraine	0.000509	0.00301	CbGpPWpGaD
Trametinib—Malnutrition—Gabapentin—migraine	0.000508	0.00179	CcSEcCtD
Trametinib—Erythema—Gabapentin—migraine	0.000508	0.00179	CcSEcCtD
Trametinib—Dizziness—Propranolol—migraine	0.000507	0.00178	CcSEcCtD
Trametinib—Asthenia—Verapamil—migraine	0.000506	0.00178	CcSEcCtD
Trametinib—MAP2K1—Developmental Biology—MEF2D—migraine	0.000505	0.00299	CbGpPWpGaD
Trametinib—MAP2K1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—FOS—migraine	0.000504	0.00298	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000503	0.00298	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000503	0.00298	CbGpPWpGaD
Trametinib—MAP2K2—MyD88:Mal cascade initiated on plasma membrane—FOS—migraine	0.000502	0.00297	CbGpPWpGaD
Trametinib—Oedema—Valproic Acid—migraine	0.0005	0.00176	CcSEcCtD
Trametinib—Bradycardia—Topiramate—migraine	0.0005	0.00176	CcSEcCtD
Trametinib—Pruritus—Verapamil—migraine	0.000499	0.00176	CcSEcCtD
Trametinib—Dysgeusia—Gabapentin—migraine	0.000498	0.00175	CcSEcCtD
Trametinib—Infection—Valproic Acid—migraine	0.000497	0.00175	CcSEcCtD
Trametinib—MAP2K1—MyD88 dependent cascade initiated on endosome—FOS—migraine	0.000495	0.00293	CbGpPWpGaD
Trametinib—MAP2K1—BDNF signaling pathway—BDNF—migraine	0.000494	0.00292	CbGpPWpGaD
Trametinib—Haemoglobin—Topiramate—migraine	0.000494	0.00174	CcSEcCtD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000494	0.00292	CbGpPWpGaD
Trametinib—Back pain—Gabapentin—migraine	0.000492	0.00173	CcSEcCtD
Trametinib—Haemorrhage—Topiramate—migraine	0.000491	0.00173	CcSEcCtD
Trametinib—Nervous system disorder—Valproic Acid—migraine	0.000491	0.00172	CcSEcCtD
Trametinib—Thrombocytopenia—Valproic Acid—migraine	0.00049	0.00172	CcSEcCtD
Trametinib—Muscle spasms—Gabapentin—migraine	0.000489	0.00172	CcSEcCtD
Trametinib—Vomiting—Propranolol—migraine	0.000488	0.00171	CcSEcCtD
Trametinib—MAP2K1—TCR Signaling Pathway—FOS—migraine	0.000486	0.00287	CbGpPWpGaD
Trametinib—Skin disorder—Valproic Acid—migraine	0.000486	0.00171	CcSEcCtD
Trametinib—Urinary tract disorder—Topiramate—migraine	0.000485	0.00171	CcSEcCtD
Trametinib—MAP2K2—MAPK Signaling Pathway—TGFBR2—migraine	0.000485	0.00287	CbGpPWpGaD
Trametinib—Oedema peripheral—Topiramate—migraine	0.000484	0.0017	CcSEcCtD
Trametinib—Hyperhidrosis—Valproic Acid—migraine	0.000484	0.0017	CcSEcCtD
Trametinib—Rash—Propranolol—migraine	0.000484	0.0017	CcSEcCtD
Trametinib—Dermatitis—Propranolol—migraine	0.000483	0.0017	CcSEcCtD
Trametinib—Diarrhoea—Verapamil—migraine	0.000483	0.0017	CcSEcCtD
Trametinib—Connective tissue disorder—Topiramate—migraine	0.000483	0.0017	CcSEcCtD
Trametinib—Urethral disorder—Topiramate—migraine	0.000481	0.00169	CcSEcCtD
Trametinib—MAP2K2—MyD88-independent cascade—FOS—migraine	0.000481	0.00285	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.00048	0.00284	CbGpPWpGaD
Trametinib—Vision blurred—Gabapentin—migraine	0.000479	0.00168	CcSEcCtD
Trametinib—MAP2K1—Toll Like Receptor 9 (TLR9) Cascade—FOS—migraine	0.000478	0.00282	CbGpPWpGaD
Trametinib—MAP2K1—Corticotropin-releasing hormone—FOS—migraine	0.000478	0.00282	CbGpPWpGaD
Trametinib—Cough—Timolol—migraine	0.000476	0.00167	CcSEcCtD
Trametinib—Hypertension—Timolol—migraine	0.000471	0.00166	CcSEcCtD
Trametinib—MAP2K2—Toll-like Receptor Signaling Pathway—FOS—migraine	0.00047	0.00278	CbGpPWpGaD
Trametinib—Anaemia—Gabapentin—migraine	0.00047	0.00165	CcSEcCtD
Trametinib—MAP2K1—MyD88:Mal cascade initiated on plasma membrane—FOS—migraine	0.000469	0.00278	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—BDNF—migraine	0.000467	0.00276	CbGpPWpGaD
Trametinib—Dizziness—Verapamil—migraine	0.000467	0.00164	CcSEcCtD
Trametinib—Arthralgia—Timolol—migraine	0.000465	0.00163	CcSEcCtD
Trametinib—Myalgia—Timolol—migraine	0.000465	0.00163	CcSEcCtD
Trametinib—MAP2K2—Ceramide signaling pathway—TNF—migraine	0.000462	0.00273	CbGpPWpGaD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000461	0.00162	CcSEcCtD
Trametinib—MAP2K2—ErbB1 downstream signaling—FOS—migraine	0.000459	0.00272	CbGpPWpGaD
Trametinib—Eye disorder—Topiramate—migraine	0.000459	0.00161	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Valproic Acid—migraine	0.000456	0.0016	CcSEcCtD
Trametinib—Cardiac disorder—Topiramate—migraine	0.000456	0.0016	CcSEcCtD
Trametinib—Nausea—Propranolol—migraine	0.000456	0.0016	CcSEcCtD
Trametinib—Leukopenia—Gabapentin—migraine	0.000455	0.0016	CcSEcCtD
Trametinib—Dry mouth—Timolol—migraine	0.000454	0.0016	CcSEcCtD
Trametinib—MAP2K1—MAPK Signaling Pathway—TGFBR2—migraine	0.000453	0.00268	CbGpPWpGaD
Trametinib—Insomnia—Valproic Acid—migraine	0.000452	0.00159	CcSEcCtD
Trametinib—MAP2K1—MyD88-independent cascade—FOS—migraine	0.00045	0.00266	CbGpPWpGaD
Trametinib—Vomiting—Verapamil—migraine	0.000449	0.00158	CcSEcCtD
Trametinib—MAP2K1—Aryl Hydrocarbon Receptor—TNF—migraine	0.000447	0.00264	CbGpPWpGaD
Trametinib—Angiopathy—Topiramate—migraine	0.000446	0.00157	CcSEcCtD
Trametinib—Oedema—Timolol—migraine	0.000445	0.00157	CcSEcCtD
Trametinib—Rash—Verapamil—migraine	0.000445	0.00156	CcSEcCtD
Trametinib—Dermatitis—Verapamil—migraine	0.000444	0.00156	CcSEcCtD
Trametinib—Cough—Gabapentin—migraine	0.000443	0.00156	CcSEcCtD
Trametinib—Mediastinal disorder—Topiramate—migraine	0.000443	0.00156	CcSEcCtD
Trametinib—Infection—Timolol—migraine	0.000442	0.00156	CcSEcCtD
Trametinib—Headache—Verapamil—migraine	0.000442	0.00155	CcSEcCtD
Trametinib—Chills—Topiramate—migraine	0.000441	0.00155	CcSEcCtD
Trametinib—MAP2K1—Toll-like Receptor Signaling Pathway—FOS—migraine	0.00044	0.0026	CbGpPWpGaD
Trametinib—Hypertension—Gabapentin—migraine	0.000439	0.00154	CcSEcCtD
Trametinib—Nervous system disorder—Timolol—migraine	0.000437	0.00154	CcSEcCtD
Trametinib—MAP2K1—MAPK Signaling Pathway—BDNF—migraine	0.000437	0.00258	CbGpPWpGaD
Trametinib—Decreased appetite—Valproic Acid—migraine	0.000435	0.00153	CcSEcCtD
Trametinib—MAP2K2—Activated TLR4 signalling—FOS—migraine	0.000433	0.00256	CbGpPWpGaD
Trametinib—Arthralgia—Gabapentin—migraine	0.000433	0.00152	CcSEcCtD
Trametinib—Myalgia—Gabapentin—migraine	0.000433	0.00152	CcSEcCtD
Trametinib—Skin disorder—Timolol—migraine	0.000433	0.00152	CcSEcCtD
Trametinib—CYP2C8—brain—migraine	0.000432	0.0124	CbGeAlD
Trametinib—MAP2K1—Ceramide signaling pathway—TNF—migraine	0.000432	0.00256	CbGpPWpGaD
Trametinib—Gastrointestinal disorder—Valproic Acid—migraine	0.000432	0.00152	CcSEcCtD
Trametinib—Fatigue—Valproic Acid—migraine	0.000431	0.00152	CcSEcCtD
Trametinib—Hyperhidrosis—Timolol—migraine	0.000431	0.00151	CcSEcCtD
Trametinib—Mental disorder—Topiramate—migraine	0.00043	0.00151	CcSEcCtD
Trametinib—MAP2K1—ErbB1 downstream signaling—FOS—migraine	0.00043	0.00254	CbGpPWpGaD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.00043	0.00151	CcSEcCtD
Trametinib—Constipation—Valproic Acid—migraine	0.000428	0.0015	CcSEcCtD
Trametinib—Malnutrition—Topiramate—migraine	0.000427	0.0015	CcSEcCtD
Trametinib—Erythema—Topiramate—migraine	0.000427	0.0015	CcSEcCtD
Trametinib—Dry mouth—Gabapentin—migraine	0.000423	0.00149	CcSEcCtD
Trametinib—Nausea—Verapamil—migraine	0.000419	0.00147	CcSEcCtD
Trametinib—Dysgeusia—Topiramate—migraine	0.000419	0.00147	CcSEcCtD
Trametinib—Oedema—Gabapentin—migraine	0.000415	0.00146	CcSEcCtD
Trametinib—MAP2K2—Cardiac Hypertrophic Response—TNF—migraine	0.000414	0.00245	CbGpPWpGaD
Trametinib—Back pain—Topiramate—migraine	0.000414	0.00145	CcSEcCtD
Trametinib—Infection—Gabapentin—migraine	0.000412	0.00145	CcSEcCtD
Trametinib—Muscle spasms—Topiramate—migraine	0.000411	0.00145	CcSEcCtD
Trametinib—Gastrointestinal pain—Valproic Acid—migraine	0.000409	0.00144	CcSEcCtD
Trametinib—MAP2K2—Toll Like Receptor 4 (TLR4) Cascade—FOS—migraine	0.000407	0.00241	CbGpPWpGaD
Trametinib—Nervous system disorder—Gabapentin—migraine	0.000407	0.00143	CcSEcCtD
Trametinib—Thrombocytopenia—Gabapentin—migraine	0.000406	0.00143	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Timolol—migraine	0.000406	0.00143	CcSEcCtD
Trametinib—MAP2K1—Activated TLR4 signalling—FOS—migraine	0.000405	0.0024	CbGpPWpGaD
Trametinib—Vision blurred—Topiramate—migraine	0.000403	0.00142	CcSEcCtD
Trametinib—Skin disorder—Gabapentin—migraine	0.000403	0.00142	CcSEcCtD
Trametinib—Insomnia—Timolol—migraine	0.000403	0.00142	CcSEcCtD
Trametinib—Hyperhidrosis—Gabapentin—migraine	0.000401	0.00141	CcSEcCtD
Trametinib—MAP2K2—PDGFR-beta signaling pathway—FOS—migraine	0.000399	0.00236	CbGpPWpGaD
Trametinib—Abdominal pain—Valproic Acid—migraine	0.000395	0.00139	CcSEcCtD
Trametinib—Body temperature increased—Valproic Acid—migraine	0.000395	0.00139	CcSEcCtD
Trametinib—Anaemia—Topiramate—migraine	0.000395	0.00139	CcSEcCtD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000394	0.00233	CbGpPWpGaD
Trametinib—MAP2K1—Cardiac Hypertrophic Response—TNF—migraine	0.000387	0.00229	CbGpPWpGaD
Trametinib—Decreased appetite—Timolol—migraine	0.000387	0.00136	CcSEcCtD
Trametinib—Gastrointestinal disorder—Timolol—migraine	0.000384	0.00135	CcSEcCtD
Trametinib—Fatigue—Timolol—migraine	0.000384	0.00135	CcSEcCtD
Trametinib—CYP3A4—nervous system—migraine	0.000383	0.011	CbGeAlD
Trametinib—Leukopenia—Topiramate—migraine	0.000383	0.00135	CcSEcCtD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—FOS—migraine	0.000382	0.00226	CbGpPWpGaD
Trametinib—MAP2K1—Toll Like Receptor 4 (TLR4) Cascade—FOS—migraine	0.000381	0.00225	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—ESR1—migraine	0.000379	0.00224	CbGpPWpGaD
Trametinib—Musculoskeletal discomfort—Gabapentin—migraine	0.000378	0.00133	CcSEcCtD
Trametinib—Insomnia—Gabapentin—migraine	0.000375	0.00132	CcSEcCtD
Trametinib—MAP2K1—PDGFR-beta signaling pathway—FOS—migraine	0.000374	0.00221	CbGpPWpGaD
Trametinib—Cough—Topiramate—migraine	0.000373	0.00131	CcSEcCtD
Trametinib—MAP2K2—Signaling by GPCR—RAMP1—migraine	0.000373	0.00221	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CALCRL—migraine	0.000373	0.00221	CbGpPWpGaD
Trametinib—Hypertension—Topiramate—migraine	0.000369	0.0013	CcSEcCtD
Trametinib—CYP3A4—central nervous system—migraine	0.000369	0.0106	CbGeAlD
Trametinib—MAP2K2—Regulation of toll-like receptor signaling pathway—FOS—migraine	0.000367	0.00217	CbGpPWpGaD
Trametinib—Gastrointestinal pain—Timolol—migraine	0.000364	0.00128	CcSEcCtD
Trametinib—Arthralgia—Topiramate—migraine	0.000364	0.00128	CcSEcCtD
Trametinib—Myalgia—Topiramate—migraine	0.000364	0.00128	CcSEcCtD
Trametinib—MAP2K2—Toll-Like Receptors Cascades—FOS—migraine	0.000363	0.00215	CbGpPWpGaD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000361	0.00127	CcSEcCtD
Trametinib—Decreased appetite—Gabapentin—migraine	0.00036	0.00127	CcSEcCtD
Trametinib—Asthenia—Valproic Acid—migraine	0.000359	0.00126	CcSEcCtD
Trametinib—Gastrointestinal disorder—Gabapentin—migraine	0.000358	0.00126	CcSEcCtD
Trametinib—MAP2K2—Downstream signaling in naïve CD8+ T cells—TNF—migraine	0.000358	0.00212	CbGpPWpGaD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—FOS—migraine	0.000358	0.00212	CbGpPWpGaD
Trametinib—Fatigue—Gabapentin—migraine	0.000358	0.00126	CcSEcCtD
Trametinib—MAP2K2—BDNF signaling pathway—FOS—migraine	0.000357	0.00211	CbGpPWpGaD
Trametinib—Dry mouth—Topiramate—migraine	0.000356	0.00125	CcSEcCtD
Trametinib—Constipation—Gabapentin—migraine	0.000355	0.00125	CcSEcCtD
Trametinib—MAP2K1—Signaling by ERBB4—ESR1—migraine	0.000355	0.0021	CbGpPWpGaD
Trametinib—Pruritus—Valproic Acid—migraine	0.000354	0.00124	CcSEcCtD
Trametinib—Body temperature increased—Timolol—migraine	0.000352	0.00124	CcSEcCtD
Trametinib—Abdominal pain—Timolol—migraine	0.000352	0.00124	CcSEcCtD
Trametinib—MAP2K1—Signaling by GPCR—RAMP1—migraine	0.000349	0.00206	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CALCRL—migraine	0.000349	0.00206	CbGpPWpGaD
Trametinib—Oedema—Topiramate—migraine	0.000349	0.00123	CcSEcCtD
Trametinib—Infection—Topiramate—migraine	0.000347	0.00122	CcSEcCtD
Trametinib—MAP2K1—Regulation of toll-like receptor signaling pathway—FOS—migraine	0.000343	0.00203	CbGpPWpGaD
Trametinib—Diarrhoea—Valproic Acid—migraine	0.000342	0.0012	CcSEcCtD
Trametinib—Nervous system disorder—Topiramate—migraine	0.000342	0.0012	CcSEcCtD
Trametinib—Thrombocytopenia—Topiramate—migraine	0.000342	0.0012	CcSEcCtD
Trametinib—MAP2K1—Toll-Like Receptors Cascades—FOS—migraine	0.000339	0.00201	CbGpPWpGaD
Trametinib—Gastrointestinal pain—Gabapentin—migraine	0.000339	0.00119	CcSEcCtD
Trametinib—Skin disorder—Topiramate—migraine	0.000339	0.00119	CcSEcCtD
Trametinib—Hyperhidrosis—Topiramate—migraine	0.000337	0.00119	CcSEcCtD
Trametinib—MAP2K1—Downstream signaling in naïve CD8+ T cells—TNF—migraine	0.000335	0.00198	CbGpPWpGaD
Trametinib—MAP2K1—BDNF signaling pathway—FOS—migraine	0.000334	0.00197	CbGpPWpGaD
Trametinib—Dizziness—Valproic Acid—migraine	0.000331	0.00116	CcSEcCtD
Trametinib—MAP2K2—Insulin Signaling—FOS—migraine	0.000328	0.00194	CbGpPWpGaD
Trametinib—Body temperature increased—Gabapentin—migraine	0.000328	0.00115	CcSEcCtD
Trametinib—Abdominal pain—Gabapentin—migraine	0.000328	0.00115	CcSEcCtD
Trametinib—MAP2K2—EGF/EGFR Signaling Pathway—FOS—migraine	0.000325	0.00192	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000324	0.00191	CbGpPWpGaD
Trametinib—Asthenia—Timolol—migraine	0.00032	0.00112	CcSEcCtD
Trametinib—Vomiting—Valproic Acid—migraine	0.000318	0.00112	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Topiramate—migraine	0.000318	0.00112	CcSEcCtD
Trametinib—Insomnia—Topiramate—migraine	0.000316	0.00111	CcSEcCtD
Trametinib—Rash—Valproic Acid—migraine	0.000315	0.00111	CcSEcCtD
Trametinib—MAP2K2—MAPK Signaling Pathway—FOS—migraine	0.000315	0.00186	CbGpPWpGaD
Trametinib—Dermatitis—Valproic Acid—migraine	0.000315	0.00111	CcSEcCtD
Trametinib—Pruritus—Timolol—migraine	0.000315	0.00111	CcSEcCtD
Trametinib—Headache—Valproic Acid—migraine	0.000313	0.0011	CcSEcCtD
Trametinib—MAP2K1—Insulin Signaling—FOS—migraine	0.000307	0.00181	CbGpPWpGaD
Trametinib—Diarrhoea—Timolol—migraine	0.000305	0.00107	CcSEcCtD
Trametinib—MAP2K1—EGF/EGFR Signaling Pathway—FOS—migraine	0.000304	0.0018	CbGpPWpGaD
Trametinib—Decreased appetite—Topiramate—migraine	0.000303	0.00107	CcSEcCtD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000303	0.00179	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—FOS—migraine	0.000302	0.00179	CbGpPWpGaD
Trametinib—Gastrointestinal disorder—Topiramate—migraine	0.000301	0.00106	CcSEcCtD
Trametinib—Fatigue—Topiramate—migraine	0.000301	0.00106	CcSEcCtD
Trametinib—Constipation—Topiramate—migraine	0.000298	0.00105	CcSEcCtD
Trametinib—Asthenia—Gabapentin—migraine	0.000298	0.00105	CcSEcCtD
Trametinib—Nausea—Valproic Acid—migraine	0.000297	0.00104	CcSEcCtD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000295	0.00175	CbGpPWpGaD
Trametinib—MAP2K2—MicroRNAs in cardiomyocyte hypertrophy—TNF—migraine	0.000295	0.00175	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—FOS—migraine	0.000295	0.00174	CbGpPWpGaD
Trametinib—Dizziness—Timolol—migraine	0.000294	0.00104	CcSEcCtD
Trametinib—Pruritus—Gabapentin—migraine	0.000293	0.00103	CcSEcCtD
Trametinib—Gastrointestinal pain—Topiramate—migraine	0.000285	0.001	CcSEcCtD
Trametinib—Diarrhoea—Gabapentin—migraine	0.000284	0.000998	CcSEcCtD
Trametinib—Vomiting—Timolol—migraine	0.000283	0.000996	CcSEcCtD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—FOS—migraine	0.000283	0.00167	CbGpPWpGaD
Trametinib—Rash—Timolol—migraine	0.000281	0.000987	CcSEcCtD
Trametinib—Dermatitis—Timolol—migraine	0.000281	0.000986	CcSEcCtD
Trametinib—Headache—Timolol—migraine	0.000279	0.000981	CcSEcCtD
Trametinib—MAP2K1—MicroRNAs in cardiomyocyte hypertrophy—TNF—migraine	0.000276	0.00163	CbGpPWpGaD
Trametinib—Abdominal pain—Topiramate—migraine	0.000276	0.00097	CcSEcCtD
Trametinib—Body temperature increased—Topiramate—migraine	0.000276	0.00097	CcSEcCtD
Trametinib—Dizziness—Gabapentin—migraine	0.000274	0.000964	CcSEcCtD
Trametinib—MAP2K2—Signaling by GPCR—HTR1D—migraine	0.000271	0.0016	CbGpPWpGaD
Trametinib—Nausea—Timolol—migraine	0.000265	0.00093	CcSEcCtD
Trametinib—Vomiting—Gabapentin—migraine	0.000264	0.000927	CcSEcCtD
Trametinib—Rash—Gabapentin—migraine	0.000261	0.000919	CcSEcCtD
Trametinib—Dermatitis—Gabapentin—migraine	0.000261	0.000918	CcSEcCtD
Trametinib—Headache—Gabapentin—migraine	0.00026	0.000913	CcSEcCtD
Trametinib—MAP2K1—Signaling by GPCR—HTR1D—migraine	0.000254	0.0015	CbGpPWpGaD
Trametinib—MAP2K2—Toll-like Receptor Signaling Pathway—TNF—migraine	0.000253	0.00149	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—HTR2B—migraine	0.000252	0.00149	CbGpPWpGaD
Trametinib—Asthenia—Topiramate—migraine	0.00025	0.00088	CcSEcCtD
Trametinib—Pruritus—Topiramate—migraine	0.000247	0.000868	CcSEcCtD
Trametinib—Nausea—Gabapentin—migraine	0.000246	0.000866	CcSEcCtD
Trametinib—Diarrhoea—Topiramate—migraine	0.000239	0.000839	CcSEcCtD
Trametinib—MAP2K1—Toll-like Receptor Signaling Pathway—TNF—migraine	0.000236	0.0014	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—HTR2B—migraine	0.000236	0.00139	CbGpPWpGaD
Trametinib—Dizziness—Topiramate—migraine	0.000231	0.000811	CcSEcCtD
Trametinib—Vomiting—Topiramate—migraine	0.000222	0.00078	CcSEcCtD
Trametinib—MAP2K2—Signaling Pathways—RAMP1—migraine	0.00022	0.0013	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CALCRL—migraine	0.00022	0.0013	CbGpPWpGaD
Trametinib—Rash—Topiramate—migraine	0.00022	0.000773	CcSEcCtD
Trametinib—Dermatitis—Topiramate—migraine	0.00022	0.000773	CcSEcCtD
Trametinib—Headache—Topiramate—migraine	0.000219	0.000768	CcSEcCtD
Trametinib—Nausea—Topiramate—migraine	0.000207	0.000729	CcSEcCtD
Trametinib—MAP2K1—Signaling Pathways—RAMP1—migraine	0.000206	0.00122	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CALCRL—migraine	0.000206	0.00122	CbGpPWpGaD
Trametinib—MAP2K2—Regulation of toll-like receptor signaling pathway—TNF—migraine	0.000197	0.00117	CbGpPWpGaD
Trametinib—MAP2K2—Disease—LRP1—migraine	0.000187	0.00111	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of toll-like receptor signaling pathway—TNF—migraine	0.000185	0.00109	CbGpPWpGaD
Trametinib—MAP2K1—Disease—LRP1—migraine	0.000175	0.00104	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—TNF—migraine	0.00017	0.001	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—HTR1B—migraine	0.000164	0.000971	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR1D—migraine	0.00016	0.000947	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—TNF—migraine	0.000159	0.000938	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—HTR1A—migraine	0.000158	0.000935	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—TAC1—migraine	0.000156	0.000921	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—NPS—migraine	0.000156	0.000921	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—HTR1B—migraine	0.000154	0.000909	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—HTR2C—migraine	0.000153	0.000903	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR1D—migraine	0.00015	0.000886	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR2B—migraine	0.000149	0.00088	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—EDNRA—migraine	0.000148	0.000878	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—HTR1A—migraine	0.000148	0.000875	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—TAC1—migraine	0.000146	0.000861	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—NPS—migraine	0.000146	0.000861	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TNF—migraine	0.000143	0.000846	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CALCA—migraine	0.000143	0.000845	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—HTR2C—migraine	0.000143	0.000845	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR2B—migraine	0.000139	0.000824	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—EDNRA—migraine	0.000139	0.000822	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CALCA—migraine	0.000134	0.000791	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—HTR7—migraine	0.000134	0.000791	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—LRP1—migraine	0.000131	0.000775	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—HTR7—migraine	0.000125	0.00074	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—LRP1—migraine	0.000123	0.000725	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CALCA—migraine	0.000121	0.000713	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—FOS—migraine	0.000118	0.000695	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CALCA—migraine	0.000113	0.000667	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—FOS—migraine	0.00011	0.00065	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NOTCH4—migraine	0.000101	0.000595	CbGpPWpGaD
Trametinib—MAP2K2—Disease—TGFBR2—migraine	9.71e-05	0.000574	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR1B—migraine	9.7e-05	0.000574	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NOTCH4—migraine	9.41e-05	0.000556	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CACNA1A—migraine	9.4e-05	0.000556	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—HTR2A—migraine	9.36e-05	0.000554	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR1A—migraine	9.34e-05	0.000552	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TAC1—migraine	9.2e-05	0.000544	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PGR—migraine	9.2e-05	0.000544	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NPS—migraine	9.2e-05	0.000544	CbGpPWpGaD
Trametinib—MAP2K1—Disease—TGFBR2—migraine	9.09e-05	0.000537	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR1B—migraine	9.07e-05	0.000537	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR2C—migraine	9.02e-05	0.000533	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—EDNRA—migraine	8.77e-05	0.000519	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—HTR2A—migraine	8.76e-05	0.000518	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR1A—migraine	8.74e-05	0.000517	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PGR—migraine	8.6e-05	0.000509	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NPS—migraine	8.6e-05	0.000509	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TAC1—migraine	8.6e-05	0.000509	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NOTCH3—migraine	8.55e-05	0.000506	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CALCA—migraine	8.44e-05	0.000499	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR2C—migraine	8.44e-05	0.000499	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—EDNRA—migraine	8.21e-05	0.000485	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NOTCH3—migraine	8e-05	0.000473	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CALCA—migraine	7.9e-05	0.000467	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR7—migraine	7.9e-05	0.000467	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MTHFR—migraine	7.89e-05	0.000467	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR7—migraine	7.39e-05	0.000437	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MTHFR—migraine	7.38e-05	0.000436	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TNF—migraine	7.15e-05	0.000423	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FOS—migraine	6.84e-05	0.000405	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TGFBR2—migraine	6.8e-05	0.000402	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TNF—migraine	6.69e-05	0.000396	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FOS—migraine	6.4e-05	0.000379	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TGFBR2—migraine	6.36e-05	0.000376	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR2A—migraine	5.53e-05	0.000327	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR2A—migraine	5.18e-05	0.000306	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CACNA1A—migraine	5.05e-05	0.000298	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ESR1—migraine	4.91e-05	0.00029	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ESR1—migraine	4.59e-05	0.000272	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MTHFR—migraine	3.11e-05	0.000184	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MTHFR—migraine	1.67e-05	9.87e-05	CbGpPWpGaD
